...
首页> 外文期刊>Acta Cardiologica >Failed thrombin treatment due to patent collateral leakage after refractory guidewire-induced coronary artery perforation
【24h】

Failed thrombin treatment due to patent collateral leakage after refractory guidewire-induced coronary artery perforation

机译:难治性导丝诱发冠状动脉穿孔后专利侧支漏出导致凝血酶治疗失败

获取原文
获取原文并翻译 | 示例
           

摘要

Ellis class III coronary artery perforation is a rare but catastrophic complication associated with high mortality and poor outcome of percutaneous coronary intervention. We describe a case of coronary artery perforation caused by a stiff hydrophilic guidewire during percutaneous coronary intervention. Leakage from patent collaterals continued despite successful embolism of the perforated artery. Although he underwent cardiac surgery, the patient died due to the rupture of a left ventricular pseudoaneurysm.
机译:Ellis III类冠状动脉穿孔是一种罕见但具有灾难性的并发症,与高死亡率和经皮冠状动脉介入治疗的不良结果相关。我们描述了经皮冠状动脉介入治疗期间由坚硬的亲水性导丝引起的冠状动脉穿孔的情况。尽管穿孔动脉成功栓塞,但仍存在从专利抵押品中泄漏的情况。尽管他接受了心脏手术,但该患者因左室假性动脉瘤破裂而死亡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号